| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/15/2008 | CA2160938C Muscle relaxant pharmaceutical compositions |
| 07/15/2008 | CA2155711C Preventive or alleviating agent for medical symptoms caused by delayed allergy reactions |
| 07/15/2008 | CA2149329C Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 07/15/2008 | CA2118235C Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them |
| 07/15/2008 | CA2113023C Tnf receptor promoter |
| 07/14/2008 | CA2675718A1 Combination of a muscarinic receptor antagonist and a beta-2-adrenoceptor agonist |
| 07/10/2008 | WO2008083370A2 Compounds, compostions, kits and methods of use to orally and topically treat acne and other skin conditions by adminstering a 19-nor containing vitamin d analog with or without a reyinoid |
| 07/10/2008 | WO2008083356A1 Substituted triazoles useful as axl inhibitors |
| 07/10/2008 | WO2008083354A1 N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors |
| 07/10/2008 | WO2008083347A1 N-halogenated amino compounds and derivatives |
| 07/10/2008 | WO2008083341A1 Crystalline forms of solvated ilaprazole |
| 07/10/2008 | WO2008083333A1 Solid state forms of racemic ilaprazole |
| 07/10/2008 | WO2008083332A1 Analgesic and anti-inflammatory compositions and methods with flavonoid glycoside -type compounds |
| 07/10/2008 | WO2008083330A2 Methods for enhancing exercise performance |
| 07/10/2008 | WO2008083326A2 Targeting of ews-fli1 as anti-tumor therapy |
| 07/10/2008 | WO2008083319A1 Solid state forms of enantiopure ilaprazole |
| 07/10/2008 | WO2008083280A1 Compounds and methods of treating insulin resistance and cardiomyopathy |
| 07/10/2008 | WO2008083256A2 Ophthalmic and otic compositions of facially amphiphilic polymers and oligomers and uses thereof |
| 07/10/2008 | WO2008083252A2 Methods of use for cyclopamine analogs |
| 07/10/2008 | WO2008083248A2 Cyclopamine analogs |
| 07/10/2008 | WO2008083238A2 Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders |
| 07/10/2008 | WO2008083226A2 Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate |
| 07/10/2008 | WO2008083200A2 Spiroheterocyclic glycosides and methods of use |
| 07/10/2008 | WO2008083174A2 Compositions and methods for the treatment of infections and tumors |
| 07/10/2008 | WO2008083160A2 Methods and compositions for therapeutic treatment |
| 07/10/2008 | WO2008083124A1 N-substituted-heterocycloalkyloxybenzamide compounds and methods of use |
| 07/10/2008 | WO2008083101A1 Phosphoramidate alkylator prodrugs for the treatment of cancer |
| 07/10/2008 | WO2008083070A1 Crf1 receptor ligands comprising fused bicyclic heteroaryl moieties |
| 07/10/2008 | WO2008083038A1 Methods and compositions for repelling arthropods |
| 07/10/2008 | WO2008083027A1 Inhibitors of poly(adp-ribose)polymerase |
| 07/10/2008 | WO2008082948A2 Ophthalmic alginate composition related methods of manufacture and methods of use |
| 07/10/2008 | WO2008082887A2 Inhibitors of poly(adp-ribose)polymerase |
| 07/10/2008 | WO2008082871A1 Formulations of levosimendan for parenteral administration |
| 07/10/2008 | WO2008082856A1 Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy |
| 07/10/2008 | WO2008082840A1 Pim kinase inhibitors as cancer chemotherapeutics |
| 07/10/2008 | WO2008082839A2 Pim kinase inhibitors as cancer chemotherapeutics |
| 07/10/2008 | WO2008082821A1 Method for promoting wound healing |
| 07/10/2008 | WO2008082725A1 Pyridazinone compounds |
| 07/10/2008 | WO2008082692A2 Isothiocyanate compounds, pharmaceutical compositions, and uses thereof |
| 07/10/2008 | WO2008082658A2 Cyclitols and their derivatives and their therapeutic applications |
| 07/10/2008 | WO2008082656A1 Glp-1 pharmaceutical compositions |
| 07/10/2008 | WO2008082637A1 Composition and methods for modulating a kinase cascade |
| 07/10/2008 | WO2008082602A2 Compounds and pharmaceutical compositions for the treatment of liver disorders |
| 07/10/2008 | WO2008082601A2 Compounds and pharmaceutical compositions for the treatment of viral infections |
| 07/10/2008 | WO2008082579A1 Method for treating cancer |
| 07/10/2008 | WO2008082567A1 Process for synthesizing a cetp inhibitor |
| 07/10/2008 | WO2008082542A1 Combination of vitamin k and vitamin k antagonist such as r-isomer of warfarin, phenprocoumon or r-isomer of phenprocoumon as anticoagulant therapy |
| 07/10/2008 | WO2008082537A2 Compounds for modulating integrin cd11b/cd18 |
| 07/10/2008 | WO2008082520A2 Inhibition of ppar gamma expression by specific osteogenic oxysterols |
| 07/10/2008 | WO2008082490A2 Novel jnk inhibitors |
| 07/10/2008 | WO2008082488A1 4, 5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 07/10/2008 | WO2008082487A2 Novel jnk inhibitors |
| 07/10/2008 | WO2008082484A1 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 07/10/2008 | WO2008082381A1 Immune response modifier formulations containing oleic acid and methods |
| 07/10/2008 | WO2008082373A2 Pharmaceutical formulations comprising lipase inhibitor |
| 07/10/2008 | WO2008082369A2 Use of coenzyme q10 for improved effectiveness of animal husbandry and production of animal tissues with an increased content of the said coenzyme |
| 07/10/2008 | WO2008082321A1 Emulsion of perfluoroorganic compounds for medical use and a methods for the preparation and the use thereof |
| 07/10/2008 | WO2008082268A1 Use of root extract of saururus chinensis for manufacture of medicament for vasorelaxation |
| 07/10/2008 | WO2008082250A1 Improved process for the preparation of non-crystalline atorvastatin calcium |
| 07/10/2008 | WO2008082200A1 Antitumoric compositions for oral administration comprising chlorin compounds |
| 07/10/2008 | WO2008082124A1 Stabilized pharmaceutical drug of atorvastatin |
| 07/10/2008 | WO2008082017A1 Cyclic sulfonium salt, method for production of cyclic sulfonium salt, and glycosidase inhibitor |
| 07/10/2008 | WO2008082009A2 Fused substituted aminopyrrolidine derivative |
| 07/10/2008 | WO2008082003A1 Fused heterocyclic compounds having crf antagonistic activity |
| 07/10/2008 | WO2008081989A1 Nerve regeneration agent |
| 07/10/2008 | WO2008081940A1 Gel composition for treating mycosis |
| 07/10/2008 | WO2008081937A1 Protein toxin secretion inhibitor |
| 07/10/2008 | WO2008081934A1 Agent for facilitating the development of brain in infant comprising milk-derived phospholipid and food composition comprising the same |
| 07/10/2008 | WO2008081928A1 Pyrazolopyrimidine compound |
| 07/10/2008 | WO2008081927A1 Method for treating cancer using anticancer agent in combination |
| 07/10/2008 | WO2008081914A1 Novel aminopyrimidine derivative as plk1 inhibitor |
| 07/10/2008 | WO2008081910A1 Novel aminopyrimidine derivatives as plk1 inhibitors |
| 07/10/2008 | WO2008081901A1 Pharmaceutical alkyl gallate composition |
| 07/10/2008 | WO2008081891A1 Orally disintegrating solid preparation |
| 07/10/2008 | WO2008081834A1 Food containing glycogen and use thereof |
| 07/10/2008 | WO2008081795A1 Method for production of dfa iii and plant extract having high dfa iii content |
| 07/10/2008 | WO2008081774A1 Orally disintegrating tablet and bitter-blocking preparation each comprising risperidone |
| 07/10/2008 | WO2008081701A1 Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 07/10/2008 | WO2008081590A1 Medical composition |
| 07/10/2008 | WO2008081580A1 Analgesic agent comprising cyclic phosphatidic acid derivative |
| 07/10/2008 | WO2008081568A1 Novel macrolide compound |
| 07/10/2008 | WO2008081537A1 Aromatic amino acid derivative with lat1 inhibitory activity, lat1 inhibitor containing the same and method for producing the same |
| 07/10/2008 | WO2008081477A1 3-aryloxy 3-substituted propanamines |
| 07/10/2008 | WO2008081399A2 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists |
| 07/10/2008 | WO2008081266A1 Compounds for the treatment or prevention of infection by flaviviridae |
| 07/10/2008 | WO2008081208A1 Piperidine gpcr agonists |
| 07/10/2008 | WO2008081207A1 Piperidine gpcr agonists |
| 07/10/2008 | WO2008081206A1 Piperidine gpcr agonists |
| 07/10/2008 | WO2008081205A1 Piperidine gpcr agonists |
| 07/10/2008 | WO2008081204A1 Piperidine gpcr agonists |
| 07/10/2008 | WO2008081175A2 Method of producing a composition from an oleogel and an aqueous gel and the composition |
| 07/10/2008 | WO2008081111A1 OLIGO-β(1→3)-GLUCANES HAVING AN ALLERGIC-REACTION INHIBITING EFFECT AND APPLICATIONS THEREOF |
| 07/10/2008 | WO2008081041A2 Amorphous and crystalline forms of rivastigmine hydrogentartrate |
| 07/10/2008 | WO2008081012A1 Spiropiperidine derivatives as nk3 antagonists |
| 07/10/2008 | WO2008081009A2 Amorphous rimonabant and rimonabant solvates and processes for their preparation |
| 07/10/2008 | WO2008080986A1 Furan derivatives, method of synthesis and uses thereof |
| 07/10/2008 | WO2008080973A1 Substituted oxindole derivatives and their use as vasopressin receptor ligands |
| 07/10/2008 | WO2008080972A1 Substituted oxindole derivative and its use as a vasopressin receptor modulator |
| 07/10/2008 | WO2008080971A1 Substituted oxindole derivative and its use as a vasopressin receptor ligand |
| 07/10/2008 | WO2008080970A1 Substituted oxindole derivative and its use as a vasopressin receptor ligand |